Intrexon Corp. (XON) Earns “Buy” Rating from JMP Securities
A number of other research firms have also recently weighed in on XON. Griffin Securities reaffirmed a buy rating and set a $55.00 price target on shares of Intrexon Corp. in a report on Tuesday, August 16th. Zacks Investment Research lowered shares of Intrexon Corp. from a buy rating to a hold rating in a research note on Friday, August 12th. Finally, Vetr upgraded shares of Intrexon Corp. from a hold rating to a strong-buy rating and set a $33.69 price objective on the stock in a research note on Wednesday, August 3rd. Four equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of Buy and an average target price of $41.71.
Shares of Intrexon Corp. (NYSE:XON) opened at 31.98 on Thursday. The stock’s market cap is $3.78 billion. The company has a 50-day moving average price of $27.27 and a 200-day moving average price of $26.79. Intrexon Corp. has a 1-year low of $18.52 and a 1-year high of $40.24.
Intrexon Corp. (NYSE:XON) last released its quarterly earnings results on Wednesday, November 9th. The company reported ($0.24) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.21) by $0.03. The business had revenue of $48.99 million for the quarter, compared to the consensus estimate of $51.70 million. Intrexon Corp. had a negative net margin of 93.97% and a negative return on equity of 18.46%. The business’s quarterly revenue was down 8.2% on a year-over-year basis. During the same period last year, the firm posted ($0.34) EPS. On average, equities analysts expect that Intrexon Corp. will post ($1.43) earnings per share for the current fiscal year.
In other Intrexon Corp. news, SVP Nir Nimrodi acquired 4,000 shares of Intrexon Corp. stock in a transaction that occurred on Monday, August 29th. The stock was acquired at an average price of $26.12 per share, with a total value of $104,480.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 55.10% of the company’s stock.
Several large investors have recently added to or reduced their stakes in XON. Columbus Circle Investors acquired a new stake in Intrexon Corp. during the second quarter valued at about $1,334,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Intrexon Corp. by 3.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 146,537 shares of the company’s stock valued at $3,606,000 after buying an additional 4,360 shares during the last quarter. California State Teachers Retirement System raised its stake in Intrexon Corp. by 12.7% in the second quarter. California State Teachers Retirement System now owns 116,869 shares of the company’s stock valued at $2,876,000 after buying an additional 13,163 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in Intrexon Corp. during the second quarter valued at about $5,312,000. Finally, Public Employees Retirement Association of Colorado raised its stake in Intrexon Corp. by 1.8% in the second quarter. Public Employees Retirement Association of Colorado now owns 12,085 shares of the company’s stock valued at $297,000 after buying an additional 209 shares during the last quarter. 84.94% of the stock is owned by institutional investors and hedge funds.
Intrexon Corp. Company Profile
Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.
Receive News & Stock Ratings for Intrexon Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corp. and related stocks with our FREE daily email newsletter.